Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/74157
Title: Role of LIMK1 in trafficking of Rab5 vesicles
Authors: Lee, Michelle Jing Qi
Keywords: DRNTU::Science
Issue Date: 2018
Abstract: Increasing evidence suggest that epithelial-mesenchymal transition (EMT) is an important source of mesenchymal cells that participate in pathological processes such as tumour invasiveness and metastasis. For the initiation or completion of EMT, reorganization and changes in cytoskeletal proteins have to take place. LIM motif containing protein kinase 1 (LIMK1) is a vital regulator of actin dynamics and overexpression of LIMK1 has been found to contribute to EMT. A growing number of studies are suggesting that LIMK1 plays a role in cytoplasmic dynein dynamics, hence, it is important to identify the downstream molecular targets affected by changes in LIMK1 activity or expression. To investigate the influence of LIMK1 on dynein activity, we performed time-lapse microscopy and immunofluorescence staining on LIMK1-knockdown HeLa cells to monitor Rab5 vesicle trafficking and N-cadherin localization. For cells with LIMK1 knockdown, we observed greater Rab5 vesicle movement speed and less localization of N-cadherin at the plasma membrane. As dynein is essential for the endocytosis of N-cadherin and trafficking of Rab5 endocytic vesicles, we conclude that dynein activity is upregulated when LIMK1 is knocked down. Thus, LIMK1 is potentially a negative regulator of cytoplasmic dynein function.
URI: http://hdl.handle.net/10356/74157
Schools: School of Biological Sciences 
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
FYP thesis.pdf
  Restricted Access
468.29 kBAdobe PDFView/Open

Page view(s)

411
Updated on May 7, 2025

Download(s) 50

27
Updated on May 7, 2025

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.